diphtheria, tetanus and pertussis vaccine infant (DTcP infant) / CanSino - LARVOL DELTA

Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine (clinicaltrials.gov) - P1 | N=260 | Not yet recruiting | Sponsor: CanSino Biologics Inc.

New P1 trial • CNS Disorders • Infectious Disease • Influenza • Meningococcal Infections • Pertussis • Respiratory Diseases • Tetanus

Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined Vaccine (clinicaltrials.gov) - P3 | N=780 | Active, not recruiting | Sponsor: CanSino Biologics Inc. | Recruiting ➔ Active, not recruiting

Enrollment closed • Infectious Disease • Pertussis • Respiratory Diseases • Tetanus

Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined Vaccine (clinicaltrials.gov) - P3 | N=780 | Recruiting | Sponsor: CanSino Biologics Inc. | Not yet recruiting ➔ Recruiting

Enrollment open • Infectious Disease • Pertussis • Respiratory Diseases • Tetanus

A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP) (clinicaltrials.gov) - P3 | N=2520 | Active, not recruiting | Sponsor: CanSino Biologics Inc. | Trial completion date: Aug 2024 ➔ Apr 2025 | Trial primary completion date: Aug 2024 ➔ Apr 2025

Trial completion date • Trial primary completion date • Infectious Disease • Pertussis • Respiratory Diseases • Tetanus

Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined Vaccine (clinicaltrials.gov) - P3 | N=780 | Not yet recruiting | Sponsor: CanSino Biologics Inc.

New P3 trial • Infectious Disease • Pertussis • Respiratory Diseases • Tetanus

A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP) (clinicaltrials.gov) - P3 | N=2520 | Active, not recruiting | Sponsor: CanSino Biologics Inc. | Recruiting ➔ Active, not recruiting | Trial primary completion date: Feb 2024 ➔ Aug 2024

Enrollment closed • Trial primary completion date • Infectious Disease • Pertussis • Respiratory Diseases • Tetanus

A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP) (clinicaltrials.gov) - P3 | N=2520 | Recruiting | Sponsor: CanSino Biologics Inc. | Not yet recruiting ➔ Recruiting

Enrollment open • Infectious Disease • Pertussis • Respiratory Diseases • Tetanus

A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP) (clinicaltrials.gov) - P3 | N=2520 | Not yet recruiting | Sponsor: CanSino Biologics Inc.

New P3 trial • Infectious Disease • Pertussis • Respiratory Diseases • Tetanus

PICTDTOV: Phase I Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed . (clinicaltrials.gov) - P1 | N=400 | Completed | Sponsor: CanSino Biologics Inc. | Unknown status ➔ Completed

Trial completion • Infectious Disease • Pertussis • Respiratory Diseases • Tetanus